2023 R&D DAY
On March 20th, 2023, the ModeX scientific leadership team gave an overview on the company’s multispecific antibody programs for cancer and infectious diseases, and detailed the state of the Epstein-Barr virus vaccine partnership with Merck announced on March 8, 2023.